Immatics (IMTX) Accumulated Expenses (2019 - 2025)
Immatics recorded quarterly Accumulated Expenses of $21.5 million in Q4 2025, up 1175.73% quarter-over-quarter from $1.7 million in Q4 2024, and up 1175.73% year-over-year from $1.7 million in Q4 2024.
Immatics' Accumulated Expenses history runs 5 years deep, the most recent figure standing at $21.5 million for Q4 2025.
- In Q4 2025, Accumulated Expenses rose 1175.73% year-over-year to $21.5 million; the TTM figure through Dec 2025 stood at $21.5 million (up 1175.73% YoY), while the FY2025 annual figure was $20.9 million, up 1138.21% from the prior year.
- Accumulated Expenses came in at $21.5 million for Q4 2025 at Immatics, up from $1.7 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $21.5 million in Q4 2025 to a low of $1.4 million in Q4 2023.
- A 3-year average of $8.2 million and a median of $1.7 million in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses increased 22.81% in 2024 and soared 1175.73% in 2025, its largest moves.
- Immatics' Accumulated Expenses stood at $1.4 million in 2023, then increased by 22.81% to $1.7 million in 2024, then jumped by 1175.73% to $21.5 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $21.5 million, $1.7 million, and $1.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.53 Mn |
| Dec 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Jun 30, 2020 | 1.06 Mn |
| Dec 31, 2019 | 365,272.93 |